The company statements in my opinion are quite confusing and lacking in detail. They do not specify what the reason for the extra testing in the statement to the ASX. . Then they suddenly announce a strategy to develop a new battery system in 2024 at the same presentation.
- Forums
- ASX - By Stock
- EBR
- Ann: Update on Submission of Final Module to FDA
Ann: Update on Submission of Final Module to FDA, page-28
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EBR (ASX) to my watchlist
|
|||||
Last
$1.08 |
Change
0.000(0.00%) |
Mkt cap ! $332.7M |
Open | High | Low | Value | Volume |
$1.10 | $1.12 | $1.08 | $127.1K | 115.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3929 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.11 | 12000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3929 | 1.060 |
1 | 10000 | 1.050 |
3 | 20256 | 1.035 |
3 | 14000 | 1.030 |
1 | 4000 | 1.020 |
Price($) | Vol. | No. |
---|---|---|
1.110 | 12000 | 1 |
1.120 | 6875 | 2 |
1.150 | 27852 | 3 |
1.155 | 10000 | 1 |
1.160 | 4800 | 1 |
Last trade - 15.59pm 26/07/2024 (20 minute delay) ? |
Featured News
EBR (ASX) Chart |